CSTONE PHARMA-B

02616

4.3203.10% ( +0.130 )

Delay Closed: Jul 31, 16:08:06

H2 2025 Earnings

Financial report interval: 2025.07.01 - 2025.12.31

Preview: CSTONE PHARMA-B(02616) predict that the Revenue is 244.79 M (+50.35%), Beat estimate;the EBIT is -172.88 M (-58.66%), Miss estimate;the EPS is -0.111 (-30.66%), Miss estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

RevenueExceed expectations

0.24B50.35%

0.23B42.01%

+0.01B8.34%

EBITMiss expectations

-0.17B58.66%

-0.05B54.08%

-0.12B112.74%

EPSMiss expectations

-0.111230.66%

-0.055634.67%

-0.055665.33%

Revenue

ActualEstimateUnit: HKD

EBIT

ActualEstimateUnit: HKD

Net income

ActualEstimateUnit: HKD

EPS

ActualEstimateUnit: HKD